Triazinium Ligation: A New Bioorthogonal Tool for Bioconjugation
Bioorthogonal chemistry continues to revolutionize the way we design molecular tools for drug development, diagnostics, and advanced therapeutics. Among the latest innovations is the triazinium ligation—a fast, selective, and fully bioorthogonal reaction with promising applications in bioconjugation.
What Is Triazinium Ligation?
The triazinium ligation is based on the reaction between a N1-alkyl 1,2,4-triazinium salt and an electron-rich dienophile. This new “click” reaction offers several attractive features:
✅ High reactivity under mild conditions
✅ Selective conjugation with electron-rich olefins
✅ Stability in biological environments, making it suitable for in vivo use
The Chemistry Behind It
Triazinium salts function as electron-deficient dienes, enabling rapid cycloaddition with electron-rich olefins via an inverse electron-demand Diels–Alder (IEDDA) mechanism.
Compared to more established systems such as tetrazines or 1,2,4-triazines, triazinium salts strike a valuable balance:
They maintain high reactivity
They also offer enhanced stability in biological media
This unique profile positions triazinium ligation as a next-generation bioorthogonal reaction for applications where both speed and stability are critical.
Why It Matters
Bioorthogonal reactions are indispensable for modern biochemistry and bioconjugation. They allow researchers to precisely modify nucleic acids, proteins, and other biomolecules without disrupting native biological processes.
By expanding the available toolkit, triazinium ligation opens new possibilities for:
Targeted drug development
Sensitive diagnostic tools
Advanced therapeutic platforms
Collaboration and Expertise
In collaboration with Prof. Milan Vrabel and his team at IOCB, Prague, SigutLabs is proud to contribute to the design and synthesis of customized triazinium salts.
Our expertise enables us to tailor these reagents to your specific bioconjugation strategies—supporting applications from early discovery to advanced therapeutic development.
Contact us to discuss how triazinium chemistry can accelerate your research.
Learn more about this groundbreaking work in Angewandte Chemie: DOI: 10.1002/anie.202306828
OUR CASE STUDY
Scale-up to accelerate drug discovery
Our experience helped overcome development hurdles for potential cancer & mental health drugs.
Read moreEmpowering neuro research with pro-N6pA
Sigut Labs scaled up pro-N6pA production, simplifying AMPylation research & boosting accessibility.
Read moreADC development leaps with new linkers
Novel linker design expedited ADC advancement, leading to promising lead compounds faster.
Read moreLincomycin derivative scale-up
Over 30 g of the desired product with exceptional purity was obtained through our optimized procedure.
Read morePurifying 350 kg of vitamin K2 oil
Our innovative scale-up technology helped to reduce the client’s purification process from days to hours.
Read more
Custom synthesis
Providing for a custom synthesis of previously reported molecules using described synthetic procedures.
Contract research
Developing novel synthetic routes to provide undescribed compounds in organic, bioorganic, and medicinal chemistry.
Scale-Up
Helping you go from lab scales to an industrial scale by applying our cutting-edge instrumentation.
Our Experts
Partners & distributors
